TNF Bound to PEGylated Gold Nanoparticles: a Platform for a Family of Cancer Nanomedicines

Lawrence  Tamarkin

Lawrence Tamarkin

President and CEO

Cytimmune Sciences Inc.

Prior to co-founding CytImmune in 1988, Dr. Tamarkin was Head of the Psychoneuroimmunology Program at the National Institute of Mental Health. Dr. Tamarkin also held research scientist positions in the National Cancer Institute and the National Institute of Child Health and Human Development. He also was an Associate Research Professor of veterinary medicine at the University of Maryland, College Park. His publications include articles in the areas of cancer, pediatrics and psychiatry. He is the co-inventor of the colloidal gold-based technology covered by thirty three issued patents and a number of pending patents. Dr. Tamarkin led CytImmune from its initial focus as a diagnostic company to its current focus on therapeutics. Dr. Tamarkin graduated from S.U.N.Y at Stony Brook with a B.S. in biology and received his Ph.D. from the University of Connecticut.

Sponsor & Exhibitor Opportunities

√ Nanotech Conference & Expo  

√ Microtech Conference & Expo  

√ Cleantech Conference & Expo  

*Sponsorship Opportunities: Contact Chris Erb

Platinum Sponsors

BASF
Bosch
Lockheed Martin
Nanocomp Technologies

Association Sponsor

Clean Technology and Sustainable Industries Organization (CTSI)

Producing Sponsors

Nano Science and Technology Institute

TechConnect

TechConnect Acceleration Partners:

Aerojet Rocketddyne
BASF
Bosch
Capewell
Corning
Daikin
Dupont
General Atomics Electromagnetics
Harris Harris Group
Ingersoll Rand
Jabil
Lockheed Martin
LORD
MWV
momentive
nationalgrid
\Oxford
Panasonic
SAINT-GOBAIN
Sabic
Shell
Sherwin Williams
SKInnovation
Union Honest Investments
UTC
*Sponsorship Opportunities: Contact Chris Erb

Free Subscription

E-mail:

pbh(); ?>